CEL-SCI Corporation (CVM) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
CEL-SCI Corporation (CVM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $9.7M, listed on AMEX, employing roughly 43 people, carrying a beta of 0.71 to the broader market. CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. Led by Geert R. Kersten, public since 1983-12-08.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for CVM as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.